Open access · OA
via OpenAlex
Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer’s pathology
Ina C. Tesseur, Kun Zou, Luke Esposito, Frédérique Bard, Elisabeth Berber, Judith Van Can, Amy H. Lin, Leslie A. Crews, Patrick J. Tremblay, Paul M. Mathews, Lennart Mucke, Eliezer Masliah, Tony Wyss‐Coray
Journal of Clinical Investigation · 2006 · ▲ 354 citations
Abstract
Alzheimer's disease (AD) is characterized by progressive neurodegeneration and cerebral accumulation of the beta-amyloid peptide (Abeta), but it is unknown what makes neurons susceptible to degeneration. We report that the TGF-beta type II receptor (TbetaRII) is mainly expressed by neurons, and that TbetaRII levels are reduced in human AD brain and correlate with pathological hallmarks of the disease. Reducing neuronal TGF-beta signaling in mice resulted in age-dependent neurodegeneration and promoted Abeta accumulation and dendritic loss in a mouse model of AD. In cultured cells, reduced TGF-beta signaling caused neuronal degeneration and resulted in increased levels of secreted Abeta and beta-secretase-cleaved soluble amyloid precursor protein. These results show that reduced neuronal TGF-beta signaling increases age-dependent neurodegeneration and AD-like disease in vivo. Increasing neuronal TGF-beta signaling may thus reduce neurodegeneration and be beneficial in AD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1172/jci27341
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Tesseur, I.C., Zou, K., Esposito, L., Bard, F., Berber, E., Can, J.V., Lin, A.H., Crews, L., Tremblay, P.J., Mathews, P.M., Mucke, L., Masliah, E., & Wyss‐Coray, T. (2006). Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer’s pathology. <em>Journal of Clinical Investigation</em>. https://doi.org/10.1172/jci27341
Vancouver
Tesseur IC, Zou K, Esposito L, Bard F, Berber E, Can JV, et al. Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer’s pathology. Journal of Clinical Investigation. 2006. doi:10.1172/jci27341.
BibTeX
@article{ina2006Defici,
title = {Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer’s pathology},
author = {Ina C. Tesseur and Kun Zou and Luke Esposito and Frédérique Bard and Elisabeth Berber and Judith Van Can and Amy H. Lin and Leslie A. Crews and Patrick J. Tremblay and Paul M. Mathews and Lennart Mucke and Eliezer Masliah and Tony Wyss‐Coray},
journal = {Journal of Clinical Investigation},
year = {2006},
doi = {10.1172/jci27341},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Biological Chemistry 2010
Open access · CC-BY
AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism
Life Sciences 1994
Citation only
Neurodegeneration, Alzheimer's disease, and beta-amyloid toxicity
Springer eBooks 2015
Citation only
Prevention of Neurodegeneration for Alzheimer’s Disease by Lycium barbarum
Metabolic Brain Disease 2023
Citation only
Estrogen signaling via estrogen receptor alpha and its implications for neurodegeneration associated with Alzheimer’s disease in aging women
Proceedings of the National Academy of Sciences 2001
Preprint · OA
β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease
Acta Neuropathologica 2015
Preprint · OA